Anti-Mouse CD357 (GITR) PE 100 ug
- Known as:
- Antibody toMouse CD357 (GITR) PE 100 ug
- Catalog number:
- 12-5874-82
- Category:
- -
- Supplier:
- eBioscience
- Gene target:
- Anti-Mouse CD357 (GITR) 100
Related genes to: Anti-Mouse CD357 (GITR) PE 100 ug
- Gene:
- TNFRSF18 NIH gene
- Name:
- TNF receptor superfamily member 18
- Previous symbol:
- -
- Synonyms:
- AITR, GITR, CD357
- Chromosome:
- 1p36.33
- Locus Type:
- gene with protein product
- Date approved:
- 1998-12-04
- Date modifiied:
- 2016-10-05
- Gene:
- TNFSF18 NIH gene
- Name:
- TNF superfamily member 18
- Previous symbol:
- -
- Synonyms:
- AITRL, TL6, hGITRL
- Chromosome:
- 1q25.1
- Locus Type:
- gene with protein product
- Date approved:
- 1999-01-15
- Date modifiied:
- 2017-03-02
Related products to: Anti-Mouse CD357 (GITR) PE 100 ug
Related articles to: Anti-Mouse CD357 (GITR) PE 100 ug
- Experimental infection with Plasmodium falciparum in malaria-naive European adults induces CD25FoxP3 regulatory CD4 T cell (Treg) expansion. Increased Treg activity is associated with reduced inflammatory cytokine responses and increased parasite growth. Whether similar associations occur in semi-immune adults from malaria-endemic regions remains unclear. In this study, we aimed to examine how inflammatory cytokines, regulatory cytokines, and Tregs influence parasitic and clinical outcomes during controlled human malaria infection in semi-immune adults from three regions in Kenya with differing degrees of P falciparum exposure. - Source: PubMed
Publication date: 2026/07/03
Kimenyi Kelvin MMorter RichardNyabundi DianaOrindi BenedictMwikali KiokoMwai KennedyKamau AliceMwacharo JedidaMusyoki JenniferKapulu MelissaAbdi Abdirahman IHill AdrianEwer KatieBejon PhilipNdungu Francis M - Immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) share symptomatic and therapeutic similarities with chronic inflammatory diseases (CIDs). However, the molecular distinctions between irAEs and CIDs remain unclear. Herein, we systematically compared irAEs and CIDs across multiple tissues using large-scale multi-omics profiling. - Source: PubMed
Publication date: 2026/06/19
Kang JunhoAn JinhyeonChoi Jung Kyoon - This research is designed to establish a prognostic framework derived from m6A- and autophagy-related lncRNAs (m6aARLncs) to enhance survival prediction in esophageal squamous cell carcinoma (ESCC). Concurrently, it endeavors to elucidate the role of prognostic framework in modulating the tumor immune microenvironment. - Source: PubMed
Publication date: 2026/05/28
Yang MingyiRen HonghaoHu JingWen PengfeiXie JialeWan XianjieLiu LinYang ZhiZhang MingRen XiaodongSu Yani - Breast cancer (BRCA) is the most common malignant tumor in women, with prognoses differing markedly by molecular subtype. Exercise is known to be related to tumor occurrence and progression, yet its role in BRCA remains understudied. This research seeks to explore the prognostic and immunomodulatory functions of exercise-related genes (ERGs) in BRCA, and their links to molecular subtypes, so as to inform targeted and precision treatment. - Source: PubMed
Publication date: 2026/05/29
Chen CaipingHan ChaoXue LiLu Xiang - Lung adenocarcinoma (LUAD) is one of the most common lung cancer subtypes worldwide, and its aggressive subtype invasive adenocarcinoma (IAC) has low survival rates. The precise identification of IAC is vital for the clinical diagnosis and treatment. The purpose of this study is to identify novel biomarkers for LUAD using single-cell and bulk RNA sequencing, so as to provide theoretical basis and practical support for the diagnosis, treatment and prognosis evaluation of lung invasive adenocarcinoma. - Source: PubMed
Publication date: 2026/03/20
Wu XiaomingYe XuxiaWang BoLi ZhouleFang ChengnanXu JianWu Mengli